A nurse is planning to administer medications to a client who weighs 198 lb. The prescription reads, "filgrastim 5 mcg/kg, subcutaneous, daily." Available is filgrastim 300 mcg/mL. How many mL should the nurse plan to give with each dose? (Round the answer to the nearest tenth. Use a leading zero if it applies. Do not use a trailing zero.)

A. This statement indicates correct understanding. Remaining upright after taking ferrous gluconate reduces the risk of esophageal irritation or discomfort, which can occur if the medication refluxes into the esophagus. This is an important teaching point for clients taking iron supplements.

B. This statement is incorrect. Antacids can interfere with the absorption of ferrous gluconate by altering stomach acidity, which is necessary for optimal iron absorption. Clients should avoid taking antacids within two hours of iron supplements.

C. This statement is incorrect. Milk and other calcium-containing products inhibit the absorption of iron. It is recommended to take ferrous gluconate with water or a source of vitamin C, such as orange juice, to enhance absorption.

D. This statement is incorrect. Black stools are a common and harmless side effect of taking iron supplements and do not typically require notifying the provider unless accompanied by other symptoms like abdominal pain or blood in the stool.

A. To assess compatibility of the verapamil with newly ordered medications: Verapamil is a calcium channel blocker used to treat hypertension, angina, and arrhythmias. It has potential interactions with many other medications due to its effects on cardiac conduction and blood
pressure. Therefore, consulting the pharmacist is important to assess compatibility and potential drug interactions when new medications are prescribed.
B. To request a change in the dosage of the verapamil: Changing the dosage of verapamil may require a healthcare provider's order rather than consultation with a pharmacist.
C. To verify the frequency of administration of the verapamil: The frequency of administration of verapamil is typically determined by the healthcare provider and documented in the prescription. The pharmacist's role may involve dispensing the medication as prescribed but not verifying the frequency unless there are discrepancies.
D. To report the client's refusal to take the verapamil: Reporting the client's refusal to take the medication should be communicated to the healthcare provider for further assessment and
intervention. The pharmacist's role is primarily related to medication dispensing and ensuring appropriate use rather than addressing client refusals.